Abstract
National malaria elimination goals across the GMS, with urgency due to artemisinin drug resistance.
Malaria market information gaps:
- Private sector readiness, contributions, and performance for appropriate case management and surveillance
- Availability and distribution chain for banned oral artemisinin monotherapy
Outlet surveys address these gaps with standardized information across the region for effective policies and strategies.